CYPSX
Price
$42.93
Change
-$2.98 (-6.49%)
Updated
Apr 4 closing price
Net Assets
24.8M
RYVLX
Price
$364.72
Change
-$50.81 (-12.23%)
Updated
Apr 4 closing price
Net Assets
646.85M
Ad is loading...

CYPSX vs RYVLX

Header iconCYPSX vs RYVLX Comparison
Open Charts CYPSX vs RYVLXBanner chart's image
ProFunds Consumer Disctnry Ultra Sec Svc
Price$42.93
Change-$2.98 (-6.49%)
VolumeN/A
Net Assets24.8M
Rydex NASDAQ-100® 2x Strategy A
Price$364.72
Change-$50.81 (-12.23%)
VolumeN/A
Net Assets646.85M
CYPSX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CYPSX vs. RYVLX commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYPSX is a Hold and RYVLX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 647M vs. CYPSX (24.8M). CYPSX (0.00) and RYVLX (0.00) have matching dividends . CYPSX was incepted earlier than RYVLX: CYPSX (21 years) vs RYVLX (21 years). CYPSX (2.62) is less costly to investors than RYVLX (2.01). RYVLX is a more actively managed with annual turnover of: 392.00 vs. CYPSX (173.00). RYVLX has a lower initial minimum investment than CYPSX: RYVLX (2500) vs CYPSX (15000). CYPSX annual gain was more profitable for investors over the last year : 5.25 vs. RYVLX (-7.99). RYVLX return over 5 years is better than : 217.08 vs. CYPSX (67.19).
CYPSXRYVLXCYPSX / RYVLX
Total Expense Ratio2.621.90138%
Annual Report Gross Expense Ratio2.622.01130%
Fund Existence21 years21 years-
Gain YTD-22.502-24.52792%
Front LoadN/A5%-
Min. Initial Investment150002500600%
Min. Initial Investment IRA15000N/A-
Net Assets24.8M647M4%
Annual Yield % from dividends0.000.00-
Returns for 1 year5.25-7.99-66%
Returns for 3 years-5.147.89-65%
Returns for 5 years67.19217.0831%
Returns for 10 years80.44459.9417%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSCX11.42N/A
N/A
Alger Health Sciences C
LMISX21.92N/A
N/A
Franklin U.S. Large Cap Equity IS
AASMX19.89N/A
N/A
Thrivent Small Cap Stock A
MWOJX58.51N/A
N/A
MFS Global Growth R4
TCIHX23.36N/A
N/A
Nuveen International Eq Idx I